Assesment of Post-stroke Elbow Flexor Spasticity in Different Forearm Positions
NCT03563209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2019-05-22
Summary
Determination of which muscle is more spastic before injection of the botulinum toxin, and the application of the targeted treatment to that muscle results in more improvement in spasticity. It is known that the muscles that flex elbow in healthy individuals change according to forearm position. While the biceps brachii flexes the forearm in supination, the brachioradialis flexes the forearm in the neutral position. The brachialis muscle acts as a primary flexor muscle when the forearm is in pronation.
In this study, hypothesis is that the severity of spasticity differs depending on the forearm position.
Conditions
- Post-stroke Elbow Spasticity
Sponsors & Collaborators
-
Izmir Katip Celebi University
lead OTHER
Principal Investigators
-
ilker şengül · İzmir Katip Çelebi University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-15
- Primary Completion
- 2018-08-15
- Completion
- 2018-08-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT02358005 ·Status: UNKNOWN ·Phase: PHASE4
-
Biomechanical and Neurophysiological Evaluation of the Effect of a Motor Block and an Injection of Botulinum Toxin on the Stiffness of the Paretic Sural Triceps Muscle
NCT04717141 ·Status: COMPLETED ·Phase: NA
-
Changes in Echogenicity and Muscle Stiffness in Elastography After Botulinum Toxin Injection a Spastic Muscle
NCT02550509 ·Status: TERMINATED ·Phase: NA
-
Comparison of Botulinum Toxin Injection Techniques in Spasticity
NCT05615987 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Oral Baclofen and Botulinum Toxin Treatments in Hemiplegic Spasticity on the Nociceptive Flexor Reflex
NCT03860662 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT01392300 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
NCT05224349 ·Status: COMPLETED
-
Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength During Locomotion in Chronic Hemiparetic Patients
NCT01821573 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Spastic Cocontractions and Limitation of Active Movements Before and After Treatment During Injection of Botulinum Toxin
NCT03453008 ·Status: UNKNOWN
-
The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination
NCT03367429 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
NCT00651690 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Repeated Botulinum Toxin Injections in Children With Cerebral Palsy
NCT05295563 ·Status: COMPLETED
-
Upper-limb Active Function and Botulinum Toxin a
NCT03783572 ·Status: RECRUITING ·Phase: NA
-
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628 ·Status: TERMINATED
-
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
NCT01444794 ·Status: COMPLETED
-
Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus
NCT06767631 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT01464307 ·Status: COMPLETED ·Phase: PHASE3
-
Muscle Elastography in Spastic Cerebral Palsy
NCT03112434 ·Status: COMPLETED
-
A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity
NCT03261167 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
NCT02580838 ·Status: UNKNOWN ·Phase: PHASE3